Product
Trilaciclib+mFOLFIRINOX
1 clinical trial
1 indication
Indication
Pancreatic CancerClinical trial
A Single-arm, Exploratory Clinical Study of Trilaciclib Combined With mFOLFIRINOX Regimen in the Treatment of Patients With Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2025-05-28